How to avoid the pitfalls when planning a platform trial: A regulators perspective
Description
View the accessible transcript of this podcast
MHRA's Kirsty Wydenbach talks to Professor Allan Gaw about the different types of complex, innovative design trials (CID) which became more commonplace during the pandemic.
She provides some practical advice for researchers and sponsors designing such trials and explains how they need to work with the MHRA to make their study happen. She highlights some potential pitfalls to be aware of, and emphasises the importance of planning, communication, transparency and clear objectives.
This podcast is part of our 'Perspectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517
To find out more about how the NIHR supports complex and innovative design trials visit: www.nihr.ac.uk/innovative-trials
United States
